Ingersoll Rand ILC Dover Acquisition 2023 Life Sciences Expansion

Ingersoll Rand announced the acquisition of ILC Dover to expand its life sciences portfolio with innovative powder management and liquid handling solutions for biopharma and pharma markets. The deal features an attractive 17x 2024E Adjusted EBITDA multiple with mid-30s margins and expands the company's addressable market by over $10 billion to approximately $65 billion.